Abstract

(S)-4[(2R, 5R, 6S)-5-Ethyl-5-hydroxy-6-methyltetrahydropyran-2-yl]pentan-4-olide (5), an alkaline degradation product of salinomycin (1), was synthesized with complete stereoselectivity from D-mannitol and ethyl L-lactate.Compound 5 was then converted to (3R, 4S, 7S)-7-[(2R, 5R, 6S)]-5-ethyl-5-methoxymethoxy-6-methyltetrahydropyran-2-yl]-4, 7-bismethoxymethoxy-3-(tetrahydropyran-2-yloxy)oct-1-yne (3), a C18-C30 segment of 1, via Sharpless asymmetric epoxidation. Another C18-C30 segment, (R)-3-[2RS, 5S]-5-[(2R, 5R, 6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2-methoxy-5-methyltetrahydrofuran-2-yl]-3-(4-methoxybenzyloxy)prop-1-yne (4), was synthesized more conveniently via coupling between a C19-C22 fragment prepared starting from D-glucose and a C23-C30 fragment prepared starting from D-mannitol and ethyl L-lactate.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.